Orion BioScience, a Delaware corporation headquartered in Kansas City, Missouri, is a start-up stage biotechnology delivery company focusing on the development of two therapeutic modalities to ameliorate the devastating effects of autoimmune and antibody-mediated diseases and associated inflammation. Two of the co-founders of Orion, Dr. Joshua Sestak and Prof. Cory Berkland, have invented disruptive technologies that Orion is developing to provide both immediate relief and long-term solutions to human diseases.
View Top Employees from Orion BioScienceWebsite | http://orionbioscience.com |
Revenue | $811000 |
Employees | 2 (1 on RocketReach) |
Address | 210 W 19th Terrace # 200, Kansas City, Missouri 64108, US |
Technologies |
JavaScript,
HTML,
Google Analytics
+6 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services |
Competitors | Collaborative Medicinal Development LLC, CuraVac Europe, Orphazyme A/S, Provention Bio, a Sanofi Company, REGiMMUNE Corporation |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular Orion BioScience employee's phone or email?
The Orion BioScience annual revenue was $811000 in 2024.
1 people are employed at Orion BioScience.
Orion BioScience is based in Kansas City, Missouri.
The NAICS codes for Orion BioScience are [54171, 54, 541, 541714, 5417].
The SIC codes for Orion BioScience are [87, 873].